TY  - RPRT
TI  - Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs
AU  - Forsberg, E. M.
AU  - Riise, R.
AU  - Saellstrom, S.
AU  - Karlsson, J. W.
AU  - Alsen, S.
AU  - Bucher, V.
AU  - Hemminki, A. E.
AU  - Olofsson Bagge, R.
AU  - Ny, L.
AU  - Nilsson, L. M.
AU  - Ronnberg, H.
AU  - Nilsson, J. A.
PY  - 2022
DO  - 10.1101/2022.09.11.507449
UR  - https://www.biorxiv.org/content/10.1101/2022.09.11.507449v1
ID  - 10.1101/2022.09.11.507449
ER  -